| Literature DB >> 26435523 |
S Córdoba1, I Balcells1, A Castelló1, C Ovilo2, J L Noguera3, O Timoneda1, A Sánchez1.
Abstract
Prolificacy can directly impact porcine profitability, but large genetic variation and low heritability have been found regarding litter size among porcine breeds. To identify key differences in gene expression associated to swine reproductive efficiency, we performed a transcriptome analysis of sows' endometrium from an Iberian x Meishan F2 population at day 30-32 of gestation, classified according to their estimated breeding value (EBV) as high (H, EBV > 0) and low (L, EBV < 0) prolificacy phenotypes. For each sample, mRNA and small RNA libraries were RNA-sequenced, identifying 141 genes and 10 miRNAs differentially expressed between H and L groups. We selected four miRNAs based on their role in reproduction, and five genes displaying the highest differences and a positive mapping into known reproductive QTLs for RT-qPCR validation on the whole extreme population. Significant differences were validated for genes: PTGS2 (p = 0.03; H/L ratio = 3.50), PTHLH (p = 0.03; H/L ratio = 3.69), MMP8 (p = 0.01; H/L ratio =4.41) and SCNN1G (p = 0.04; H/L ratio = 3.42). Although selected miRNAs showed similar expression levels between H and L groups, significant correlation was found between the expression level of ssc-miR-133a (p < 0.01) and ssc-miR-92a (p < 0.01) and validated genes. These results provide a better understanding of the genetic architecture of prolificacy-related traits and embryo implantation failure in pigs.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26435523 PMCID: PMC5155628 DOI: 10.1038/srep14416
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Functional enrichment analysis showing the top significantly-over-represented GO terms in which identified DEG are involved.
| GO:0007565 | Female pregnancy | 2.892 | 0.00000 | 0.0001 | 8 |
| GO:0001893 | Maternal placenta development | 4.035 | 0.00004 | 0.0243 | 3 |
| GO:0046697 | Decidualization | 4.218 | 0.00002 | 0.0243 | 3 |
| GO:0048545 | Response to steroid hormone | 2.100 | 0.00004 | 0.0243 | 7 |
| GO:0000038 | Long-chain fatty acid metabolism | 3.812 | 0.00007 | 0.0307 | 3 |
| GO:0006694 | Steroid biosynthetic process | 2.267 | 0.00025 | 0.0722 | 5 |
| GO:0009888 | Tissue development | 1.284 | 0.00030 | 0.0722 | 12 |
| GO:0001503 | Ossification | 1.993 | 0.00026 | 0.0722 | 6 |
| GO:0042127 | Regulation of cell proliferation | 1.264 | 0.00035 | 0.0722 | 12 |
| GO:0060348 | Bone development | 1.957 | 0.00032 | 0.0722 | 6 |
| GO:0009725 | Response to hormone | 1.605 | 0.00036 | 0.0722 | 8 |
| GO:0001501 | Skeletal system development | 1.578 | 0.00043 | 0.0785 | 8 |
| GO:0043129 | Surfactant homeostasis | 4.314 | 0.00056 | 0.0942 | 2 |
| GO:0007398 | Ectoderm development | 1.813 | 0.00066 | 0.0969 | 6 |
| GO:0051216 | Cartilage development | 2.396 | 0.00066 | 0.0969 | 4 |
aOdds ratio logarithmic transformation.
bBenjamini-Hochberg FDR-corrected p-value.
Results summary for the selected candidate genes.
| RNA-seq analysis | Log2FC | RT-qPCR analysis | FC | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biosynthesis of prostaglandins (PTG) | Atli MO | – | Female pregnancy (GO:0007565) | 102.14 | 28.40 | 1.85 | 0.032 | 0.271 | 0.160 | 1.69 | 0.118 | |
| Palliser HK | ||||||||||||
| Kowalewski MP | ||||||||||||
| Collagen metabolism and preeclampsia | Mousa AA | NNIP | Embryo development (GO:0009790) | 68.49 | 8.64 | 2.99 | 0.008 | 0.152 | 0.034 | 4.44 | 0.013 | |
| Remodeling of the cervical and fetal membrane ECM | Wang H | |||||||||||
| Converts arachidonic acid to PGH2 | Waclawik A. | GEST | Maternal placenta development (GO:0001893) | 109.91 | 6.57 | 4.06 | 0.008 | 0.129 | 0.037 | 3.50 | 0.027 | |
| Blitek A. t al. 2006 | ||||||||||||
| Rate-limiting enzymes in PG synthesis | Blitek A. | |||||||||||
| Sales KJ | ||||||||||||
| Essential to reproduction | Murakami M. | |||||||||||
| Lim H | ||||||||||||
| Langenbach R | ||||||||||||
| Silver RM | ||||||||||||
| Nipple development during pregnancy | Martínez-Giner M | NSB | Lactation | 286.09 | 14.36 | 4.32 | 0.008 | 0.108 | 0.029 | 3.69 | 0.027 | |
| Preimplantation | Guo L | |||||||||||
| Fetoplacental development | Thota CS | |||||||||||
| Embryonic mammary development | Hiremath M | |||||||||||
| Preeclaampsia | Marino G | OVRATE | Response to hypoxia (GO:0001666) | 33.29 | 2.65 | 3.65 | 0.008 | 0.140 | 0.041 | 3.42 | 0.048 | |
| BW | Sodium ion transport (GO:0006814) | |||||||||||
aIn the RNAseq analysis, expression values are shown as RPKM values (Reads per Kilobase of exon model per Million mapped reads) and mean difference between groups as the log2 transformed fold change (Log2FC).
bIn the RT-qPCR analysis, expression values are shown as mean relative quantities (RQ) and mean difference between groups is represented as the fold change (FC).
Figure 1(a) RT-qPCR analysis results for gene expression. Expression values were calculated applying the −2∆∆CT algorithm. Estimated relative quantities were normalized for the expression value of two uterus endogenous genes B2MG and UBC and calibrated to the sample with a higher expression. Significance was set at a p-value < 0.05 (*). (b) RT-qPCR analysis results for miRNA expression. Relative quantities were calculated using target-specific amplification efficiencies and normalized for the expression level of two uterus reference miRNAs: has-miR-93 (M = 0.464; CV = 0.156 and ssc-miR-103 (M = 0.464; CV = 0.166).
Results summary for the validated candidate miRNAs.
| Angiosenesis | Bellera N. | 51,874.13 | 21,710.41 | −1.26 | 0.032 | 0.376 | 0.347 | 1.09 | 0.515 | ||
| Embryo implantation | Su L. | ||||||||||
| Placentation | Su L. | ||||||||||
| trophoblast differentiation | Kumar P. | ||||||||||
| Ginecological tumors | Torres A. | 430.21 | 187,19 | −1.20 | 0.034 | 0.231 | 0.247 | 0.94 | 0.829 | ||
| Embryo implantation | Chakrabarty A. | ||||||||||
| Endometriosis | Teague E. | ||||||||||
| Uterine tumors | Torres A. | 533.76 | 1,777.17 | 1.74 | 0.050 | 0.168 | 0.255 | 0.66 | 0.290 | ||
| Skeletal muscle development | Lee J. | ||||||||||
| Hypoxia | Shen G. | 55.51 | 124.35 | 1.16 | 0.046 | 0.580 | 0.611 | 0.95 | 0.698 | ||
| Embryo implantation | Su L. | ||||||||||
| Placentation | Su L. | ||||||||||
| Endometrial stromal decidualization | Estella C. | ||||||||||
aIn the RNAseq analysis, expression values are shown as RPKM values (Reads per Kilobase of exon model per Million mapped reads) and mean difference between groups as the log2 transformed fold change (Log2FC).
bIn the RT-qPCR analysis, expression values are shown as mean relative quantities (RQ) and mean difference between groups is represented as the fold change (FC).
Pearson’s correlations between miRNA expression values obtained by RT-qPCR and validated target genes expression.
| Pearson’s correl. | −0.575 | −0.537 | −0.533 | −0.516 | |
| 0.0003* | 0.0007* | 0.0008* | 0.0013* | ||
| N | 36 | 36 | 36 | 36 | |
| Pearson’s correl. | −0.140 | −0.139 | −0.088 | −0.137 | |
| 0.4159 | 0.4199 | 0.6113 | 0.4240 | ||
| N | 36 | 36 | 36 | 36 | |
| Pearson’s correl. | −0.059 | −0.045 | −0.069 | −0.123 | |
| 0.7380 | 0.7889 | 0.6925 | 0.4824 | ||
| N | 35 | 35 | 35 | 35 | |
| Pearson’s correl. | 0.630 | 0.574 | 0.615 | 0.551 | |
| 0.00004* | 0.0002* | 0.00007* | 0.0005* | ||
| N | 36 | 36 | 36 | 36 |
Significance was set at a p-value < 0.05. (*)Correlation is significant at the 0.01 level (bilateral).
Figure 2Ingenuity Pathway Analysis (IPA) Core Analysis-based network.
Links of validated genes and other genes or molecules are represented with a continuous (direct interaction) or discontinuous line (indirect interaction).
Network associations of upstream regulators and validated candidate genes predicted by Ingenuity Pathway Analysis (IPA).
| Dexamethasone | Chemical drug | 0.000001 | |
| Cytokine | 0.000007 | ||
| Cytokine | 0.000079 | ||
| Lipopolysaccharide | Chemical drug | 0.000097 |
The Core Analysis calculates the predicted upstream regulators based on the FC direction (up-regulated or down-regulated) observed among known downstream targets.
Phenotypic records of the F2 Iberian × Meishan sows used in this study.
| HIGH | A1 (791) | 12.00 | 10.00 | 13.00 | 10 | 1.73 |
| A2 (787) | 11.75 | 13.00 | 16.00 | 16 | 1.68 | |
| A3 (169) | 12.25 | 11.00 | 14.00 | 11 | 1.68 | |
| A4 (332) | 12.75 | 13.33 | 16.00 | 14 | 1.55 | |
| A5 (373) | 11.25 | 11.00 | 20.00 | 17 | 1.50 | |
| A6 (878) | 12.00 | 10.50 | 14.00 | 7 | 1.42 | |
| A7 (425) | 11.00 | 11.00 | 0.00 | 13 | 1.34 | |
| A8 (767) | 9.40 | 10.50 | 17.00 | 14 | 1.31 | |
| A9 (20) | 11.00 | 10.00 | 20.00 | 14 | 1.22 | |
| A10 (127) | 11.00 | 11.67 | 17.00 | 13 | 1.21 | |
| A11 (365) | 10.50 | 10.00 | 16.00 | 9 | 1.17 | |
| A12 (389) | 10.25 | 10.50 | 19.00 | 16 | 1.09 | |
| A13 (597) | 10.00 | 9.50 | 20.00 | 11 | 0.92 | |
| A14 (151) | 10.75 | 12.00 | 20.00 | 13 | 0.89 | |
| A15 (874) | 10.25 | 10.00 | 11.00 | 8 | 0.82 | |
| A16 (271) | 10.50 | 9.67 | 15.00 | 14 | 0.81 | |
| A17 (30) | 10.75 | 10.67 | 19.00 | 13 | 0.80 | |
| A18 (485) | 11.00 | 12.50 | 16.00 | 16 | 0.77 | |
| Average (HIGH) | ||||||
| LOW | A19 (350) | 4.50 | 3.00 | 15.00 | 6 | −2.48 |
| A20 (309) | 5.00 | 4.33 | 16.00 | 8 | −2.42 | |
| A21 (360) | 5.00 | 5.33 | 18.00 | 1 | −2.33 | |
| A22 (260) | 4.75 | 5.00 | 17.00 | 10 | −2.31 | |
| A23 (173) | 5.00 | 6.67 | 15.00 | 10 | −2.30 | |
| A24 (861) | 5.50 | 5.00 | 24.00 | 9 | −2.04 | |
| A25 (409) | 4.75 | 5.67 | 18.00 | 11 | −1.94 | |
| A26 (918) | 7.00 | 8.50 | 16.00 | 13 | −1.46 | |
| A27 (779) | 6.25 | 5.50 | 23.00 | 10 | −1.45 | |
| A28 (915) | 4.75 | 4.00 | 18.00 | 8 | −1.21 | |
| A29 (443) | 5.25 | 6.50 | 16.00 | 5 | −1.13 | |
| A30 (702) | 6.00 | 7.50 | 13.00 | 11 | −1.06 | |
| A31 (322) | 4.75 | 5.00 | 16.00 | 14 | −0.95 | |
| A32 (204) | 5.00 | 3.67 | 14.00 | 15 | −0.95 | |
| A33 (486) | 5.25 | 3.50 | 24.00 | 5 | −0.91 | |
| A34 (499) | 6.75 | 6.50 | 13.00 | 11 | −0.59 | |
| A35 (895) | 7.25 | 8.50 | 13.00 | 10 | −0.46 | |
| A36 (846) | 6.75 | 5.00 | 22.00 | 14 | −0.45 | |
| Average (LOW) | − |
aNBA (number of piglets born alive) and TNB (total number of piglets born) trait entries correspond to the average for four consecutive parities.
bOR (number of corpora lutea) and NF (number of foetuses) recorded at slaughter on the fifth gestation.
cExtreme samples used for mRNA libraries preparation and sequencing.
dExtreme samples used for microRNA libraries sequencing.
Primers used for the genes RT-qPCR validation design.
| ACCTTCTGGTCCACACTGAGTTC | GGTCTCGATCCCACTTAACTATCTTG | Endogenous | 300 nM | |
| CAGGCACAACTTAGAGATACATTTAGG | TCCAGCATTATTGACCAAAATGTC | Target gene | 300 nM | |
| GGACCAAAACCTCCAAAAATTACA | TGAGACAGCCCCAAGGAATG | Target gene | 300 nM | |
| ACGAGCAGGCTGATACTGATAGG | GTGGTAGCCACTCAGGTGTTGTAC | Target gene | 300 nM | |
| GCCGCCGACTCAAAAGAG | CGCCGTAAATCTTGGATGGA | Target gene | 300 nM | |
| GCTGCCTACTCCCTGCAGATC | TACTGAGCGCACCCACATTTC | Target gene | 300 nM | |
| GCATTGTTGGCGGTTTCG | AGACGCTGTGAAGCCAATCA | Endogenous | 300 nM |
Primers used for the miRNAs RT-qPCR validation design.
| CAAAGTGCTGTTCGTGCAGGTAG | GCAAAGTGCTGTTCGTG | TCCAGTTTTTTTTTTTTTTTCTACCT | 200 nM | |
| TATTGCACTTGTCCCGGCCTGT | AGGTGTGTATAAAGTATTGCACTTGTCC | CAGGTCCAGTTTTTTTTTTTTTTTACAG | 250 nM | |
| TACAGTACTGTGATAACTGAA | GCTGTATATCTGAAAGGTACAGTACTGTGAT | GGTCCAGTTTTTTTTTTTTTTTCAGTT | 250 nM | |
| AGCAGCATTGTACAGGGCTATGA | AGAGCAGCATTGTACAGG | GGTCCAGTTTTTTTTTTTTTTTCATAG | 250 nM | |
| TTGGTCCCCTTCAACCAGCTG | GAATGGATTTGGTCCCCTTCA | CAGTTTTTTTTTTTTTTTCAGCTGGT | 250 nM | |
| AACATTCAACGCTGTCGGTGAGTT | CACAATCAACATTCATTGTTGTCG | TCCAGTTTTTTTTTTTTTTTAACCCAC | 250 nM |